Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.
AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.
To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.
AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.
Topics covered are:
• drug design
• molecular modelling/docking studies
• pharmaceutical chemistry/medicinal chemistry
• drug metabolism
• analytics of drugs
• pharmaceutical technology/formulation studies/nanosystems/cosmetology
• pharmaceutical biotechnology
• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics
• drug delivery/disposition and stability
• pharmacognosy and phytopharmacy
• pharmacology (clinical and animal)
• toxicology
• clinical pharmacy
• pharmacovigilance
• pharmaceutical and clinical biochemistry
• pharmaceutical biology with genetics/pharmacogenomics/cell biology
• pharmacoepidemiology/pharmacoeconomics/social pharmacy
• physical pharmacy
• radiopharmaceuticals
• medicine (including diagnostics and therapy)
• peptide and protein chemistry/protein design
《ACTA PHARMACEUTICA》期刊已被查看: 次
此期刊被最新的JCR期刊SCIE收录
期刊官网:https://sciendo.com/journal/ACPH |
---|
期刊投稿网址:Submit By Email: acta.pharmaceutica@farmaceut.org or svjetlana.luterotti@gmail.com or svjetlana.luterotti@pharma.hr |
PubMed Central (PMC)链接 :http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1330-0075%5BISSN%5D |
通讯地:HRVATSKO FARMACEUTSKO DRUSTOV (HFD)-CROATION PHARMACEUTICAL SOC, MASARYKOVA 2, ZAGREB, CROATIA, 10000 |
中国科学院《国际期刊预警名单(试行)》名单 |
2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 此期刊被最新的JCR期刊SCIE收录 |
版面费 | 审稿速度 | 收录数据库 | 是否oa | 研究方向 |
---|---|---|---|---|
文章处理费:需要( EUR900; ) 文章处理费豁免:没有 其他费用:没有 |
>12周,或约稿 | SCIE,Scopus,DOAJ | Yes | PHARMACOLOGY & PHARMACY- |
大类学科 | 分区 | 小类学科 | Top期刊 | 综述期刊 |
---|---|---|---|---|
医学 | 4区 | PHARMACOLOGY & PHARMACY 药学 |
否 | 否 |
版本 | 按学科 | 分区 | 影响因子 |
---|---|---|---|
2023-2024年最新版 | PHARMACOLOGY & PHARMACY | Q3 | 2.1 |
Journal of Inclusive Postsecondary EducationJCR:0区,分类:影响因子0收录DOAJ
详情StichprobenJCR:0区,分类:影响因子0收录DOAJ
详情EManagementJCR:0区,分类:影响因子0收录DOAJ
详情Metathesis Journal of English Language Literature and TeachingJCR:0区,分类:影响因子0收录DOAJ
详情Clinical Psychology in EuropeJCR:0区,分类:影响因子0收录Scopus,DOAJ
详情Ius InkarriJCR:0区,分类:影响因子0收录DOAJ
详情Medichna nauka UkrayiniJCR:0区,分类:影响因子0收录DOAJ
详情Economics LawJCR:0区,分类:影响因子0收录DOAJ
详情